Elevated serum levels of parathormone, osteocalcin, bone-specific alkaline phosphatase, and low 25-hydroxyvitamin D3 levels have been proposed as markers of ongoing bone disease in the follow-up of CeD patients [138]. Here, BGLAP is linked to cranioectodermal dysplasia.